Summary
- Profile Type
- Technology offer
- POD Reference
- TOHU20230608008
- Term of Validity
- 8 June 2023 - 7 June 2025
- Company's Country
- Hungary
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The Hungarian SME works on its own or its industrial and academic partner’s cyclodextrins and carbohydrates related preclinical drug development programs. The SME focuses on developing advanced applications of cyclodextrins in the pharmaceutical sector. Besides acting as a contract research organization, research collaboration is sought from partners who are interested in developing new applications of cyclodextrins.
- Full Description
-
The company is pharmaceutical start up from Hungary, founded in 2022, with the aim of discovering and developing new applications of cyclodextrins. The company also works as a CRO (Contract Research Organization) supporting other companies on the existing and innovative applications of cyclodextrins in their preclinical drug development programs. The team consists of seasoned cyclodextrin scientists with deep experience in synthesis, formulation, analytical, manufacturing and regulatory aspects of cyclodextrins.
The company’s own pipeline program focuses on new applications of cyclodextrins, such as drugs, gene delivery platform or the biotechnology uses. Targeted therapeutic areas are central nervous system indications and rare diseases.
The company is part of an ongoing Horizon grant and is open to join or initiate other similar grants. - Advantages and Innovations
-
The company has unique experience in the field of the existing and new applications of cyclodextrins.
Cyclodextrins are ingredients in more than 100 different approved medicines but the use of cyclodextrins as active ingredients for various indications started to flourish in the late 2000s.
The team members have supported many companies having cyclodextrins related drugs in various clinical phases. - Stage of Development
- Lab tested
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- Secret know-how
Partner Sought
- Expected Role of a Partner
-
-Type of partner sought: Industrial and academic partners both for collaborative type of projects, common grants, etc.
- Specific area of activity of the partner: Preclinical and clinical drug development.
- Task to be performed: Any kind of research collaboration in the field of advanced or existing applications of cyclodextrins. - Type and Size of Partner
- SME 11-49
- University
- SME <=10
- R&D Institution
- SME 50 - 249
- Type of partnership
- Research and development cooperation agreement
Dissemination
- Technology keywords
- 05001004 - Organic Chemistry
- 06002007 - In vitro Testing, Trials
- 05001001 - Analytical Chemistry
- 06001015 - Pharmaceutical Products / Drugs
- Market keywords
- 05005022 - Other clinical medicine
- Sector Groups Involved
- Health
- Targeted countries
- All countries